J IRAN CHEM SOC
obtain 1,3-bis(4-arylthiazol-2-yl)benzene derivatives as off-
white or light yellow powders.
Compound 3f: 1H NMR (500 MHz, CDCl3): δ 8.04–7.99
(m, 2H), 7.95–7.91 (m, 2H), 7.45 (s, 1H), 7.44–7.40 (m,
2H), 7.19–7.13 (m, 2H); 13C NMR (125 MHz, CDCl3): δ
166.9 (C-2 thiazole), 165.0 (C-4 thiazole), 163.0, 155.2,
134.1, 132.9, 130.0, 128.9, 128.6, 128.5, 127.7, 116.1,
115.9, 112.8 (C-5 thiazole); Anal. Calcd. for C15H9ClFNS:
C, 62.18; H, 3.13; Cl, 12.24; F, 6.56; N, 4.83; S, 11.07
Found: C, 62.24; H, 3.17; Cl, 12.18; F, 6.51; N, 4.78; S,
11.11.
Spectral data of compounds 3a–3l
1
Compound 3a: H NMR (500 MHz, CDCl3): δ 8.42 (m,
4H), 8.07 (m, 4H), 7.52 (m, 6H); 13C NMR (125 MHz,
CDCl3): δ 164.9 (C-2 thiazole), 162.9 (C-4 thiazole), 134.4,
130.2, 128.8, 128.5, 128.2, 126.5, 116.1, 115.9, 112.5 (C-5
thiazole); Anal. Calcd. for C15H11NS: C, 75.91; H, 4.67; N,
5.90; S, 13.51 Found: C, 75.84; H, 4.71; N, 5.79; S, 13.57.
1
Compound 3g: H NMR (500 MHz, CDCl3): δ 8.05–
8.00 (m, 2H), 7.87 (d, j = 8.5 Hz, 2H), 7.58 (d, j = 8.5 Hz,
2H), 7.49 (s, 1H), 7.19–7.14 (m, 2H); 13C NMR (125 MHz,
CDCl3): δ 166.9 (C-2 thiazole), 165.0 (C-4 thiazole),
163.0, 155.2, 133.3, 131.9, 130.0, 128.6, 128.5, 128.0,
122.2, 116.1, 115.9, 112.9 (C-5 thiazole); Anal. Calcd.
for C15H9BrFNS: C, 53.91; H, 2.71; Br, 23.91; F, 5.68; N,
4.19; S, 9.59 Found: C, 53.85; H, 2.66; Br, 23.97; F, 5.74;
N, 4.14; S, 9.52.
1
Compound 3b: H NMR (500 MHz, CDCl3): δ 8.07–
8.05 (m, 2H), 7.91 (d, j = 8.0 Hz, 2H), 7.50–7.44 (m, 3H),
7.43 (s, 1H), 7.27 (d, j = 8.0 Hz, 2H), 2.41 (s, 3H); 13C
NMR (125 MHz, CDCl3): δ 166.7 (C-2 thiazole), 162.3
(C-4 thiazole), 156.7, 138.3, 131.6, 130.8, 129.3, 128.6,
128.2, 126.2, 116.7, 111.8 (C-5 thiazole), 20.7; Anal.
Calcd. for C16H13NS: C, 76.46; H, 5.21; N, 5.57; S, 12.76
Found: C, 76.34; H, 5.31; N, 5.70; S, 12.59.
1
Compound 3h: H NMR (500 MHz, CDCl3): δ 7.95
Compound 3c: 1H NMR (500 MHz, CDCl3): δ 8.06–8.03
(m, 2H), 7.96–7.93 (m, 2H), 7.50–7.40 (m, 6H); 13C NMR
(125 MHz, CDCl3): δ 168.1 (C-2 thiazole), 155.1 (C-4 thi-
azole), 134.0, 133.6, 133.0, 130.2, 128.94, 128.89, 127.7,
126.6, 112.8 (C-5 thiazole); Anal. Calcd. for C15H10ClNS:
C, 66.29; H, 3.71; Cl, 13.05; N, 5.15; S, 11.80 Found: C,
66.34; H, 3.61; Cl, 13.13; N, 5.10; S, 11.69.
(d, j = 8.7 Hz, 2H), 7.87 (d, j = 8.4 Hz, 2H), 7.57 (d,
j = 8.4 Hz, 2H), 7.40 (s, 1H), 6.98 (d, j = 8.7 Hz, 2H),
3.88 (s, 3H);13C NMR (125 MHz, CDCl3): δ 168.0 (C-2
thiazole), 161.3 (C-4 thiazole), 154.9, 133.6, 131.8, 128.1,
128.0, 126.6, 122.0, 114.3, 112.1 (C-5 thiazole), 55.4;
Anal. Calcd. for C16H12BrNOS: C, 55.50; H, 3.49; Br,
23.08; N, 4.05; S, 9.26 Found: C, 55.56; H, 3.45; Br, 23.13;
N, 3.99; S, 9.21.
Compound 3d: 1H NMR (500 MHz, CDCl3): δ
8.01–7.98 (m, 4H), 7.47–7.43 (m, 2H), 7.41 (s, 1H),
7.38–7.34 (m, 1H), 7.01–6.97 (m, 2H), 3.88 (s, 3H); 13C
NMR (125 MHz, CDCl3): δ 168.8 (C-2 thiazole), 161.3
(C-4 thiazole), 154.7, 133.5, 131.3, 128.3, 127.2, 126.5,
122.2, 114.6, 112.1 (C-5 thiazole), 54.4; Anal. Calcd. for
C16H13NOS: C, 71.88; H, 4.90; N, 5.24; S, 11.99 Found: C,
71.74; H, 4.97; N, 5.18; S, 12.04.
Compound 3i: 1H NMR (500 MHz, CDCl3): δ 8.06–8.02
(m, 2H), 7.89 (d, j = 8.1 Hz, 2H), 7.41 (s, 1H), 7.26 (d,
j = 7.9 Hz, 2H), 7.19–7.13 (m, 2H), 2.41 (s, 3H); 13C NMR
(125 MHz, CDCl3): δ 166.5 (C-2 thiazole), 164.9 (C-4
thiazole), 162.9, 156.5, 138.1, 131.8, 130.2, 129.4, 128.53,
128.47, 126.4, 116.0, 115.8, 111.7 (C-5 thiazole), 21.3;
Anal. Calcd. for C16H12FNS: C, 71.35; H, 4.49; F, 7.05; N,
5.20; S, 11.91 Found: C, 71.28; H, 4.46; F, 7.11; N, 5.16;
S, 11.94.
1
Compound 3e: H NMR (500 MHz, CDCl3): δ 8.07–
8.02 (m, 2H), 8.01–7.98 (m, 2H), 7.47 (s, 1H), 7.45 (d,
j = 7.8 Hz, 2H), 7.37 (t, j = 7.4 Hz, 1H), 7.19–7.13 (m,
2H); 13C NMR (125 MHz, CDCl3): δ 164.9 (C-2 thiazole),
162.9 (C-4 thiazole), 156.4, 134.4, 130.2, 128.7, 128.6,
128.5, 128.2, 126.5, 116.1, 115.9, 112.5 (C-5 thiazole); Anal.
Calcd. for C15H10FNS: C, 70.57; H, 3.95; F, 7.44; N, 5.49; S,
12.56 Found: C, 70.49; H, 3.90; F, 7.49; N, 5.42; S, 12.49.
1
Compound 3j: H NMR (500 MHz, CDCl3): δ 8.68 (s,
1H), 8.14 (d, j = 7.8 Hz, 1H), 8.13 (d, j = 7.8 Hz, 1H), 8.05
(d, j = 7.7 Hz, 4H), 7.58 (t, j = 7.7 Hz, 1H), 7.54 (s, 2H),
7.49 (t, j = 7.6 Hz, 4H), 7.39 (t, j = 7.5 Hz, 2H); 13C NMR
(125 MHz, CDCl3): δ 167.0 (C-2 thiazole), 156.6 (C-4
thiazole), 134.6, 134.5, 129.5, 128.8, 128.3, 128.1, 126.5,
Scheme 2 Application of bisthioamides for the synthesis of 1,3-bis(4-arylthiazol-2-yl)benzene derivatives
1 3